⌘K

Login Start Free

Home/Filings/4/0001437749-16-031865

4//SEC Filing

Aviragen Therapeutics, Inc. 4

Accession 0001437749-16-031865

$VXRTCIK 0000072444operating

View on SEC.gov Company Profile

Filed

May 12, 8:00 PM ET

Accepted

May 13, 5:06 PM ET

Size

5.0 KB

Accession

0001437749-16-031865

Insider Transaction Report

Form 4

Period: 2016-05-12

Aviragen Therapeutics, Inc.AVIR

Director

Transactions

Award
Stock Option (Right to Buy)
2016-05-12$1.50/sh+20,000$30,000→ 20,000 total
Exercise: $1.50From: 2017-05-12Exp: 2026-05-12→ Common Stock (20,000 underlying)

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

Aviragen Therapeutics, Inc.

CIK 0000072444

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000072444

Filing Metadata

Form type: 4
Filed: May 12, 8:00 PM ET
Accepted: May 13, 5:06 PM ET
Size: 5.0 KB

View on SEC.gov